Velliquette, Rodney A <br/><br/>
Lipid-lowering actions of imidazoline antihypertensive agents in metabolic syndrome X.  [electronic resource] 

 -  Naunyn-Schmiedeberg's archives of pharmacology  Jan 2006 
 - 300-12 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0028-1298 
<br/><br/><label>Standard No.: </label>10.1007/s00210-005-0024-3  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adrenergic alpha-2 Receptor Agonists<br/>Adrenergic alpha-2 Receptor Antagonists<br/>Adrenergic alpha-Agonists--pharmacology<br/>Adrenergic alpha-Antagonists--pharmacology<br/>Animals<br/>Antihypertensive Agents--pharmacology<br/>Cell Membrane--drug effects<br/>Cholesterol--blood<br/>Clonidine--pharmacology<br/>Disease Models, Animal<br/>Female<br/>Guanabenz--pharmacology<br/>Hyperlipidemias--drug therapy<br/>Imidazoles--pharmacology<br/>Imidazoline Receptors<br/>Liver--drug effects<br/>Male<br/>Metabolic Syndrome--drug therapy<br/>Oxazoles--pharmacology<br/>Rats<br/>Rats, Inbred SHR<br/>Receptors, Drug--agonists<br/>Rilmenidine<br/>Triglycerides--blood